The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort
- PMID: 9116988
- DOI: 10.1164/ajrccm.155.3.9116988
The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort
Abstract
The association between serum beta-carotene or retinol concentration and level of ventilatory function was investigated in a population of asbestos-exposed men with a high rate of current and former cigarette smoking. The study population consisted of 816 subjects enrolled in the pilot component of the Carotene and Retinol Efficacy Trial (CARET), a placebo-controlled trial of supplemental beta-carotene and retinyl palmitate for the chemoprevention of lung cancer. Data available for analysis included baseline questionnaire, spirometry, chest X-ray, food frequency questionnaire, and serum beta-carotene and retinol concentrations. Serum beta-carotene concentration was associated with FEV1 (p < 0.05) and FVC (p < 0.05), with an approximately 100-ml increase over predicted values associated with raising the serum concentration from the 25th to the 75th percentile of the distribution in the study population (absolute difference = 155 ng/ml), even after adjustment for the confounding effects of asbestos exposure and cigarette smoking. Raising the serum retinol concentration from the 25th to the 75th percentile (absolute difference = 211 ng/ml) was associated with an approximately 70 ml increase in FVC (p < 0.05) over the predicted value. These results provide support for the hypothesis that beta-carotene and retinol have a protective effect on loss of ventilatory function.
Similar articles
-
The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer.Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):815-21. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8896893
-
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):381-7. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8348062 Clinical Trial.
-
The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.Cancer Res. 1994 Apr 1;54(7 Suppl):2038s-2043s. Cancer Res. 1994. PMID: 8137335 Clinical Trial.
-
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):389-96. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8348063 Clinical Trial.
-
Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.Eur J Cancer Prev. 2007 Jun;16(3):184-91. doi: 10.1097/01.cej.0000215612.98132.18. Eur J Cancer Prev. 2007. PMID: 17415088 Review.
Cited by
-
Vitamin A - discovery, metabolism, receptor signaling and effects on bone mass and fracture susceptibility.Front Endocrinol (Lausanne). 2024 Apr 22;15:1298851. doi: 10.3389/fendo.2024.1298851. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38711977 Free PMC article. Review.
-
Plasma retinol, carotene and vitamin E concentrations and lung function in a crocidolite-exposed cohort from Wittenoom, Western Australia: a cohort study.Nutr J. 2005 May 11;4:16. doi: 10.1186/1475-2891-4-16. Nutr J. 2005. PMID: 15888203 Free PMC article.
-
Antioxidant supplements for preventing gastrointestinal cancers.Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD004183. doi: 10.1002/14651858.CD004183.pub3. Cochrane Database Syst Rev. 2008. PMID: 18677777 Free PMC article.
-
A multivariate analysis of serum nutrient levels and lung function.Respir Res. 2008 Sep 29;9(1):67. doi: 10.1186/1465-9921-9-67. Respir Res. 2008. PMID: 18823528 Free PMC article.
-
Drugs for preventing lung cancer in healthy people.Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD002141. doi: 10.1002/14651858.CD002141.pub3. Cochrane Database Syst Rev. 2020. PMID: 32130738 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical